Cosmetic Regulation Update's Link With OTC Drug User Fees Clear At Hearing

Members of the House Health Subcommittee suggest their support for potential OTC monograph reform legislation depends on including provisions that would add substantial details to FDA's oversight of cosmetics manufacturers and a related user fee program.